Literature DB >> 27056343

Early echocardiographic predictor of heart failure in cerebral arteriovenous malformations.

Poonam P Thankavel1, Claudio Ramaciotti1.   

Abstract

Neonatal congestive heart failure in cerebral arteriovenous malformations carries a high risk of mortality. Severe heart failure leading to end-organ dysfunction may be a contraindication to early intervention. Although echocardiographic markers of haemodynamic instability exist, an objective echocardiographic predictor of severe heart failure is not available. We present a ratio of antegrade to retrograde flow in the aortic arch that objectively identifies those at the highest risk of mortality. This measurement can be easily obtained and has prognostic value at presentation, before clinical deterioration. Outcomes remain poor even when early intervention is offered, which may reflect irreversible neurological abnormalities.

Entities:  

Keywords:  Arteriovenous malformation; congestive heart failure; prognostic marker

Mesh:

Year:  2016        PMID: 27056343     DOI: 10.1017/S1047951116000305

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  3 in total

1.  [Intracranial vascular malformations].

Authors:  D F Vollherbst; M Bendszus; M A Möhlenbruch
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

Review 2.  Vein of Galen aneurysmal malformation: rationalizing medical management of neonatal heart failure.

Authors:  Melinda J Cory; Dimitrios Angelis; Phillippe Durand; Rafael Sillero; Luc Morin; Rashmin Savani; Lina Chalak
Journal:  Pediatr Res       Date:  2022-04-14       Impact factor: 3.756

3.  Effects of inhaled nitric oxide (iNO) in pulmonary hypertension secondary to arteriovenous malformations: a retrospective cohort study from the European iNO registry.

Authors:  Aravanan Anbu Chakkarapani; Samir Gupta; Asma Jamil; Santosh Kumar Yadav; Nim Subhedar; Helmut D Hummler
Journal:  Eur J Pediatr       Date:  2022-09-06       Impact factor: 3.860

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.